Diabetes : (Record no. 42643)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01788nam a22002177a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 210901b2021 |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9780367544577 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9780367544591 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9781003089391 |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | WK 810 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal author | Kumar, Awanish |
245 1# - TITLE STATEMENT | |
Title | Diabetes : |
Subtitle | epidemiology, pathophysiology and clinical management |
260 ## - PUBLICATION INFORMATION | |
Place of publication | Boca Raton, Florida : |
-- | Abingdon : |
Publisher | CRC Press, |
Date | 2021 |
300 ## - PHYSICAL DESCRIPTION | |
Physical description | xxi, 221p |
520 ## - ABSTRACT | |
Abstract | Diabetes: Epidemiology, Pathophysiology and Clinical Management aims to be the one-stop diabetes book for researchers, scientists and clinicians. It details the epidemiology, causes, molecular mechanisms, molecular markers, available drugs, experimental drugs, treatment modalities, and dietary and lifestyle approaches related to diabetes. It focuses on various molecular aspects of diabetes, and its related co-morbidities. Apart from the drug-based treatment approach based on international guidelines, this book also describes various surgical treatments available for cases of uncontrolled symptomatic diabetes. It also lays emphasis on the future possibilities of different approaches for diabetes management. Key Features Includes treatment guidelines and approaches to diabetes provided by major global diabetes associations Provides a thorough and comprehensive assimilation of detailed information and updates in the field of diabetes, helpful for researchers, scientists and clinicians Contains a chapter on anti-diabetic drugs, that covers both the commercially approved drugs as well as those that are in various phases of experimental, pre-clinical, and clinical trials. |
650 ## - SUBJECT HEADINGS | |
Subject term | Endocrinology |
9 (RLIN) | 6049 |
650 ## - SUBJECT HEADINGS | |
Subject term | Diabetes |
650 ## - SUBJECT HEADINGS | |
Subject term | Obesity: treatment & therapy |
700 1# - ADDED PERSONAL NAME | |
Added personal author | Kumar, Ashwini |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Suppress in OPAC | Do not Suppress in OPAC |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Source of acquisition | Cost, normal purchase price | Total Checkouts | Total Renewals | Full call number | Barcode | Date last seen | Date last borrowed | Cost, replacement price | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
National Library of Medicine | Stenhouse Library | Stenhouse Library | Shelves | 01/09/2021 | Tomlinsons | 42.99 | 1 | 4 | WK 810 | S04026 | 20/03/2023 | 11/01/2023 | 42.99 | 01/09/2021 | Book |